The latest London South East Webinar takes place on July 6. Come and hear CEO’s from Orosur Mining, Caledonia Mining, Glantus Holdings and Tekcapital speak. Please register here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.25
Bid: 21.00
Ask: 21.50
Change: 0.25 (1.19%)
Spread: 0.50 (2.38%)
Open: 21.25
High: 21.40
Low: 21.25
Yest. Close: 21.00
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Mon, 14th Dec 2020 16:59

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:



Tracsis PLC - Leeds-based provider of software, hardware and services for rail, traffic data and transport industries - Chief Financial Officer Max Cawthra sells 75,000 shares at 638.7p, worth GBP479,025, on Monday. Still has 93,022 shares, a 0.3% stake.



Checkit PLC - Cambridge, England-based workflow management - Executive Chair Keith Daley buys 413,775 shares at 50.1 pence, worth GBP207,301, on Friday last week. Now holds 14.8 million shares, a 23.8% stake.



London Stock Exchange Group PLC - trading and clearing operator and index calculator - Non-Executive Director Dominic Blakemore buys 928 shares at GBP86.21, worth GBP79,999, on Monday.



Aquila Services Group PLC - London-based consultancy and support services in affordable housing, education, sports and community services sectors - Directors and associates buy 360,000 shares at 20p, worth GBP72,000, on Thursday last week. Chair Derek Joseph, Non-Executive Director Richard Wollenberg and Executive Director Fiona Underwood each buy 120,000 shares.



Ocean Wilsons Holdings Ltd - Bermuda-based investment company operating a maritime services company in Brazil - Non-Executive Director Caroline Foulger buys 5,000 shares at 874p, worth GBP42,700, on December 4 and 7. Now interested in 10,000 shares.



Spirax-Sarco Engineering PLC - Cheltenham, England-based thermal energy management and pumping - Non-Executive Director Caroline Johnstone buys 443 shares at 11,241.89p, worth GBP49,802, on Thursday last week.



Audioboom Group PLC - London-based podcasts producer - Non-Executive Chair Michael Tobin buys 10,050 shares at 199p, worth GBP20,000, on Friday. Now has 280,616 shares, a 1.8% stake.



Shield Therapeutics PLC - Newcastle, England-based pharmaceutical firm focussed on iron deficiency - Chief Executive Officer Tim Watts buys 100,000 shares at GBP0.70, worth GBP69,750, on Friday. Now has 548,700 shares.



React Group PLC - South Derbyshire-based cleaning, hygiene and decontamination - Executive Chair Mark Braund buys 774,255 shares and CFO Andrea Pankhurst buys 463,458, both at 1.29p and together worth GBP15,966, on Friday. The shares are their only holdings. Braund was appointed at the start of this month and Pankhurst in May.



SimplyBiz Group PLC - Zahid Bilgrami, CEO of Defaqto subsidiary, sells 55,000 shares at 180.00p, worth GBP99,000, on Friday. Still interested in 1.8 million shares. SimplyBiz bought Defaqto, a financial services technology firm with a platform that rates financial products and funds, for GBP74 million in March 2019.



Churchill China PLC - Stoke-On-Trent, England-based ceramic products for hospitality and retail markets - CEO David O'Connor buys 4,850 shares at 1,340p, worth GBP64,990, while Finance Director David Taylor and Sales & Marketing Director James Roper each sell 2,000 shares at 1,272p, all on Friday. O'Connor now has 37,963 shares, while Taylor has 59,555. Roper has 1.0 million shares, a 9.1% stake.



Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 248,823 shares via Vulpes Life Sciences Fund at 10.50p, worth about GBP26,126, on Friday. Vulpes now has 117.5 million shares, a 14.4% stake.



JPMorgan China Growth & Income PLC - seeks total return from companies listed in Hong Kong, China and Taiwan - Non-Executive Director Alexandra Mackesy buys 1,600 shares at 641.78p, worth GBP10,268, on Friday last week.



By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

7 Jun 21 13:58

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

7 Jun 21 10:38

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

30 Apr 21 14:30

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

19 Feb 21 20:13

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

19 Feb 21 12:40

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

17 Feb 21 16:22

Scancell ends clinical development partnership with Cancer Research UK

(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.

3 Feb 21 14:53

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

3 Feb 21 11:20

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

3 Feb 21 11:11

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

3 Feb 21 09:48

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

29 Jan 21 15:05

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

21 Dec 20 19:39

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

18 Dec 20 10:45

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

18 Dec 20 10:26

Scancell selects Covid-19 vaccine candidate for development and trials

(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.

18 Dec 20 10:17

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.